Confirmation of a relationship of breast cancer risk hyperinsulinemia or with plasma IGF-I levels, could open up new perspectives to be used in primary prevention, as a normal reference pattern, moreover, data from the metabolic profile can be used to elaborate a mathematical model of breast carcinogenesis, or the use of certain chemopreventive drugs. This evidence concerns the gene IGF1 and breast carcinoma.